| Nov 12 |
High Growth Tech Stocks Featuring Three Prominent US Companies
|
| Nov 8 |
Why Neurocrine Biosciences Stock Is Very Attractive At Current Levels
|
| Nov 8 |
Neurocrine Biosciences' (NASDAQ:NBIX) Strong Earnings Are Of Good Quality
|
| Nov 7 |
Neurocrine Biosciences Presents New KINECT®-HD Data Showing Consistent Efficacy Across 19 Subgroups and Improvements in Aspects of Emotional Health With INGREZZA® (valbenazine) Capsules
|
| Nov 5 |
Neurocrine Biosciences to Participate at Investor Conferences in November
|
| Nov 4 |
Neurocrine Biosciences Presents Breadth of Data Demonstrating Holistic Improvements Over Time in Patients With Tardive Dyskinesia Following Treatment With INGREZZA® (valbenazine) Capsules
|
| Nov 4 |
Neurocrine Biosciences Presents New Data on INGREZZA® (valbenazine) Capsules at Psych Congress 2024: Majority of Long-Term Study Participants Achieved Remission of Tardive Dyskinesia
|
| Oct 31 |
Neurocrine Biosciences Inc (NBIX) Q3 2024 Earnings Call Highlights: Strong Sales and Strategic ...
|
| Oct 31 |
Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
|
| Oct 30 |
Neurocrine Biosciences, Inc. (NBIX) Q3 2024 Earnings Call Transcript
|
